RECENT NEWS

Molecular diagnostics firm Sense Biodetection has announced a new partnership with R-Biopharm. for the non-exclusive distribution in the Netherlands, Belgium, and Luxembourg of Sense’s Veros instrument-free, point-of-care molecular testing platform.

QIAGEN has launched a monkeypox (now renamed mpox by WHO) test for its NeuMoDx automated PCR platform to strengthen surveillance and research into the current outbreak.

Aquyre Biosciences has recognised Lung Cancer Awareness Month by reaching a milestone of over 400 lung biopsy procedures completed using the CelTivity microscopy system.

Fujifilm Irvine Scientific is to establish a cell culture media manufacturing facility in Research Triangle Park (RTP), North Carolina, USA, which will triple the company’s current capacity for liquid cell culture media production.

PerkinElmer has launched ready-to-use adeno-associated virus vectors (AAV) detection kits to support researchers working on gene therapies for a variety of serious diseases.

QuantuMDx and its exclusive UK distributor Menarini are launching the new Q-POC rapid, point-of-care PCR testing device for SARS-CoV-2.

PCR Biosystems has launched a new family of qPCR reagents mixes: Clara Probe Mix, Clara Probe 1-Step Mix and Clara HRM Mix. The cutting-edge Clara family of mixes rely on a novel composition to push the boundaries of performance to meet the challenges of today’s laboratories.

Proscia, a provider of digital and computational pathology solutions, has announced new research on improving the generalisation of an artificial intelligence (AI) classification model with contrastive self-supervised learning.

The Lab Innovations show returned to the NEC, Birmingham, earlier this month to drive sustainability and innovation in laboratories and celebrate its tenth anniversary.

Enalees, a company specialising in the design, development, production and marketing of state-of-the-art rapid molecular diagnostic tests, such as LAMP PCR (Loop-mediated isothermal AMPlification Polymerase Chain Reaction), for the veterinary profession, has announced the establishment of its first European subsidiary in North Yorkshire, UK.

Torrey Pines Scientific has launched the new EchoTherm RHB20 series of remotely controlled heating stations for robotic systems, fume hoods and controlled environmental chambers.

Bio-Rad Laboratories has announced the launch of the Pioneer Antibody Discovery Platform, a new antibody discovery service specifically designed to develop best-in-class biologic candidates.

NIPACS+ will support the creation of regional networks of care and will help the region to transform diagnostic services, as healthcare professionals benefit from a single point of access to medical images.

UK genomics company RevoluGen has announced an agreement with Tecan for the manufacturing and supply of Tecan’s 96-well filter plates to be used in RevoluGen’s automated Fire Monkey High Molecular Weight (HMW)-DNA extraction kits.

Life science imaging systems manufacturer Evident Corporation and Ultivue, an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies, have announced a collaborative agreement to promote whole slide imaging using multiplexed immunofluorescence (mIF) assays to advance translational research in the Americas.

EnteroBiotix, a full-spectrum microbiome therapeutics company, has announced a partnership with Imperial College London to develop microbiome R&D in patients suffering from blood cancer as well as accelerate systematic research in the new science of the microbiome.

BIOHIT HealthCare is excited to be exhibiting at this year’s British Society for Immunology (BSI) Congress in Liverpool.

Diagnostica Stago is launching qLabs FIB - a novel POC device which measures fibrinogen levels from a single drop of whole blood, further expanding the company’s near-patient testing solutions for the critical care setting.

NHS patients throughout the West Midlands are to benefit from a digital pathology programme, designed to help reduce cancer backlogs, transform services, and improve the speed and accuracy of cancer diagnosis.

Red blood cells that have been grown in a laboratory have now been transfused into another person in a world first clinical trial. The manufactured blood cells were grown from stem cells from donors. The red cells were then transfused into volunteers in the RESTORE randomised controlled clinical trial.